Daping Li

Title: Daping Li: Innovator in Pharmaceutical Advancements

Introduction

Daping Li, a prominent inventor based in Guangdong, China, has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts. With a focus on addressing critical health issues, Daping has secured one patent that showcases the potential impact of his work on cancer treatment and other diseases.

Latest Patents

Daping Li's noteworthy patent is titled "Multi-target kinase inhibitor, pharmaceutical composition, and preparation method for multi-target kinase inhibitor and use thereof." This invention presents a multi-target kinase inhibitor, designed to effectively disrupt the enzymatic activities of RET, VEGFR3, and PDGFRA. The inhibitor's abilities extend to treating various cancers, including those of the breast, respiratory tract, brain, reproductive organ, digestive tract, urinary tract, eye, liver, skin, head and neck, as well as lymphoma, sarcoma, and leukemia. The pharmaceutical composition features a multi-target kinase inhibitor, making up 1-50 wt % of the entire formulation, thereby supporting the therapeutic needs associated with abnormal signal transduction pathways.

Career Highlights

Throughout his career, Daping Li has made a significant impact in the biotechnology field, having worked for notable organizations. He has contributed his expertise while employed at Guangzhou Liushun Biotechnology Co., Ltd. and Beijing Beikehuaxia Biomedical Technology Co., Ltd. His innovative outlook and dedication have positioned him as a valuable asset in both companies, driving important projects forward.

Collaborations

In his professional journey, Daping Li has collaborated with distinguished colleagues, including Bing Liu and Jingsi Dai. Their combined efforts have strengthened research initiatives and propelled new discoveries in the biomedical sector, further enhancing the potential applications of their findings.

Conclusion

Daping Li exemplifies the spirit of innovation in the pharmaceutical industry, particularly with his work on multi-target kinase inhibitors. His patent signifies the potential for advanced treatment options for various forms of cancer and other diseases linked to multi-target kinases. As his career progresses, the contributions of Daping Li to the field of biotechnology will undoubtedly continue to influence future advancements in medicine.